{"log_id": 5900497545234623175, "direction": 0, "words_result_num": 28, "words_result": [{"probability": {"variance": 2.3e-05, "average": 0.997227, "min": 0.974738}, "location": {"width": 827, "top": 175, "height": 49, "left": 204}, "words": "验)。由于这些报告由不确定数量的人群自发报告,通常不可能可靠地估计其发"}, {"probability": {"variance": 0.001493, "average": 0.990004, "min": 0.770693}, "location": {"width": 829, "top": 224, "height": 46, "left": 203}, "words": "生频率或与药物暴露量建立因果关系。在开始西格列汀二甲双胍治疗后必须仔细"}, {"probability": {"variance": 1.8e-05, "average": 0.997469, "min": 0.981094}, "location": {"width": 810, "top": 272, "height": 47, "left": 206}, "words": "观察患者的症状和体征。若怀疑胰腺炎,必须立即停用本品并给予相应的治疗"}, {"probability": {"variance": 0.000132, "average": 0.995712, "min": 0.93502}, "location": {"width": 830, "top": 321, "height": 47, "left": 206}, "words": "目前尚未在既往有胰腺炎病史的患者中进行西格列汀二甲双胍的研究。目前还不"}, {"probability": {"variance": 3e-05, "average": 0.997294, "min": 0.976863}, "location": {"width": 833, "top": 369, "height": 46, "left": 204}, "words": "清楚既往有胰腺炎病史的患者使用西格列汀二甲双胍是否会增加胰腺炎发生的"}, {"probability": {"variance": 2.7e-05, "average": 0.997154, "min": 0.974834}, "location": {"width": 715, "top": 419, "height": 43, "left": 212}, "words": "风险。必须将急性胰腺炎的特征性症状告知患者:持续性、重度腹痛"}, {"probability": {"variance": 0.000235, "average": 0.99485, "min": 0.907324}, "location": {"width": 830, "top": 505, "height": 48, "left": 208}, "words": "监测肾功能:已知二甲双胍和西格列汀都主要通过肾脏排泄。随着肾功能损害程"}, {"probability": {"variance": 0.000317, "average": 0.993341, "min": 0.904613}, "location": {"width": 829, "top": 554, "height": 43, "left": 209}, "words": "度加重,二甲双胍在体内蓄积和乳酸酸中毒的发生风险相应增加。因此血清肌酐"}, {"probability": {"variance": 1e-06, "average": 0.999206, "min": 0.997352}, "location": {"width": 833, "top": 600, "height": 45, "left": 209}, "words": "水平超过其年龄相应的正常值上限的患者,不能服用本品。对于高龄患者,应当"}, {"probability": {"variance": 4e-06, "average": 0.998999, "min": 0.988251}, "location": {"width": 830, "top": 647, "height": 47, "left": 213}, "words": "谨慎调整本品的剂量,用最低药物剂量达到适当的血糖控制效果,因为年龄的增"}, {"probability": {"variance": 2e-06, "average": 0.998442, "min": 0.994986}, "location": {"width": 267, "top": 706, "height": 35, "left": 214}, "words": "加是与肾功能降低相关的"}, {"probability": {"variance": 0.000166, "average": 0.996726, "min": 0.922299}, "location": {"width": 831, "top": 743, "height": 45, "left": 215}, "words": "已有关于肾功能恶化的上市后报告,包括急性肾衰竭,有时需要透析。在开始本"}, {"probability": {"variance": 3.9e-05, "average": 0.997954, "min": 0.962334}, "location": {"width": 830, "top": 790, "height": 46, "left": 215}, "words": "品治疗前应当先评价患者的肾功能并确保肾功能正常,开始服药后每年至少检查"}, {"probability": {"variance": 2.2e-05, "average": 0.997797, "min": 0.974102}, "location": {"width": 803, "top": 836, "height": 45, "left": 242}, "words": "次肾功能。对于估计肾功能正在恶化的患者,尤其是老年人,应当经常检查肾"}, {"probability": {"variance": 0.002893, "average": 0.981476, "min": 0.756241}, "location": {"width": 525, "top": 888, "height": 41, "left": 219}, "words": "功能,一旦发现肾功能损害时应立即停止本品治疗"}, {"probability": {"variance": 1.6e-05, "average": 0.996648, "min": 0.988305}, "location": {"width": 146, "top": 989, "height": 27, "left": 223}, "words": "磷酸西格列汀"}, {"probability": {"variance": 5.6e-05, "average": 0.995922, "min": 0.96749}, "location": {"width": 828, "top": 1020, "height": 47, "left": 221}, "words": "过敏反应:在接受本品成分之一西格列汀治疗的患者中,曾出现严重的过敏反应"}, {"probability": {"variance": 2e-05, "average": 0.998312, "min": 0.973602}, "location": {"width": 828, "top": 1067, "height": 45, "left": 223}, "words": "的上市后报告。这些不良反应包括过敏症、血管性水肿和脱性皮肤损害,包括"}, {"probability": {"variance": 0.000714, "average": 0.989786, "min": 0.874458}, "location": {"width": 825, "top": 1112, "height": 49, "left": 223}, "words": " Stevens- Johnson综合征。由于这些反应由不确定数量的人群自发报告,通常不可"}, {"probability": {"variance": 0.001152, "average": 0.989844, "min": 0.820689}, "location": {"width": 828, "top": 1160, "height": 47, "left": 224}, "words": "能可靠地估计其发生频率或与药物暴露量建立因果关系。这些不良反应在开始西"}, {"probability": {"variance": 0.000106, "average": 0.997089, "min": 0.9396}, "location": {"width": 818, "top": 1209, "height": 46, "left": 224}, "words": "格列汀治疗后3个月内发生,其中部分报告见于首次给药后。如果怀疑过敏反应"}, {"probability": {"variance": 5e-06, "average": 0.998655, "min": 0.991178}, "location": {"width": 826, "top": 1256, "height": 46, "left": 228}, "words": "必须停止本品治疗,评估导致不良事件的其它潜在原因并开始针对糖尿病的其他"}, {"probability": {"variance": 0.000165, "average": 0.992, "min": 0.96311}, "location": {"width": 471, "top": 1309, "height": 39, "left": 228}, "words": "治疗。(参见禁忌和不良反应,上市后经验。)"}, {"probability": {"variance": 0.002071, "average": 0.966741, "min": 0.887239}, "location": {"width": 146, "top": 1405, "height": 31, "left": 232}, "words": "盐酸二甲双胍"}, {"probability": {"variance": 0.000293, "average": 0.992816, "min": 0.903073}, "location": {"width": 830, "top": 1436, "height": 49, "left": 229}, "words": "乳酸酸中毒:乳酸酸中毒是一种罕见但严重的代谢系统并发症,可以在本品(磷"}, {"probability": {"variance": 0.01063, "average": 0.975387, "min": 0.44163}, "location": {"width": 694, "top": 1487, "height": 44, "left": 233}, "words": "酸西格列盐酸二甲双胍)治疗过程中因为二甲双胍的蓄积而发生"}, {"probability": {"variance": 0.000561, "average": 0.981882, "min": 0.948392}, "location": {"width": 74, "top": 1485, "height": 28, "left": 972}, "words": "旦发生"}, {"probability": {"variance": 1.5e-05, "average": 0.997231, "min": 0.984385}, "location": {"width": 827, "top": 1531, "height": 48, "left": 231}, "words": "致死率在50%左右。乳酸酸中毒的发生还与许多病理生理情况有关,包括糖尿病"}], "language": 3}